Diabetes Metab J.  2021 Sep;45(5):791-792. 10.4093/dmj.2021.0190.

Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)

• Lee CH

• KMID: 2520862
• DOI: http://doi.org/10.4093/dmj.2021.0190

Reference

1. Chung JW, Park YS, Seo JE, Son Y, Oh CW, Lee CH, et al. Clinical impact of dysglycemia in patients with an acute myocardial infarction. Diabetes Metab J. 2021; 45:270–4.

2. Rezende PC, Rahmi RM, Hueb W. The influence of diabetes mellitus in myocardial ischemic preconditioning. J Diabetes Res. 2016; 2016:8963403.

3. Rezende PC, Rahmi RM, Uchida AH, da Costa LM, Scudeler TL, Garzillo CL, et al. Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients. Cardiovasc Diabetol. 2015; 14:66.

4. Lee SA, Cho SJ, Jeong MH, Kim YJ, Kim CJ, Cho MC, et al. Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients. Diabetes Care. 2014; 37:2366–73.